Haematologist Dr Sue Pavord was one of the jab’s biggest supporters, but she knew something was wrong when she saw the ...

Spreading its geographic wings further, in the face of ongoing difficulties in China, UK pharma major AstraZeneca has ...

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a ...

The Food and Drug Administration (FDA) last week granted the first approval for UK pharma major AstraZeneca’s Datroway ...

Even before the FDA's recent approval of Dato-DXd in breast cancer, analysts predicted sales of the antibody-drug conjugate ...

Labour aims to capitalise on the growth potential of the cluster of businesses and academic institutes around Oxford, ...

Diversify Wealth Management LLC grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 3.6% during the ...

New jobs are coming to a Mississauga company. Officials gathered at the Mississauga-based biopharmaceutical company ...

Ameritas Advisory Services LLC increased its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 25.9% during the fourth quarter, according to the company in its most recent disclosure ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

SNY, ABBV, RHHBY and NVS will announce Q4 results and regular pipeline and regulatory updates next week.